CureVac NV (MEX:CVAC) Operating Cash Flow per Share : MXN15.15 (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is CureVac NV Operating Cash Flow per Share?

CureVac NV's operating cash flow per share for the three months ended in Sep. 2024 was MXN34.36. CureVac NV's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was MXN15.15.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for CureVac NV's Operating Cash Flow per Share or its related term are showing as below:

During the past 6 years, CureVac NV's highest 3-Year average Operating Cash Flow per Share Growth Rate was -42.90% per year. The lowest was -110.30% per year. And the median was -76.60% per year.

MEX:CVAC's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.5
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

CureVac NV Operating Cash Flow per Share Historical Data

The historical data trend for CureVac NV's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CureVac NV Operating Cash Flow per Share Chart

CureVac NV Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-10.36

95.63

-91.36

-31.26

-22.46

CureVac NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-5.03	-3.60	-7.77	-7.83	34.36

Competitive Comparison of CureVac NV's Operating Cash Flow per Share

For the Biotechnology subindustry, CureVac NV's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CureVac NV's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CureVac NV's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CureVac NV's Price-to-Operating-Cash-Flow falls into.

CureVac NV Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

CureVac NV's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-4958.757	/	220.833
	=	-22.45

CureVac NV's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )	=	Cash Flow from Operations (Q: Sep. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
	=	7738.004	/	225.220
	=	34.36

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN15.15

CureVac NV Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of CureVac NV's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

CureVac NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (MEX:CVAC) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

CVAC:USA 1CVAC:Italy 0A9E:UK 5CV:Germany CVAC:Austria

Address

Friedrich-Miescher-Strasse 15, Tubingen, BW, DEU, 72076

Website

https://www.curevac.com

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.